Aclaris Therapeutics, Inc.
← Back to ACRS Overview

Aclaris Therapeutics, Inc. (ACRS)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-6.25

Financial Fundamentals

ACRSQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2014-03-31-2.20
2014-06-30-2.20
2014-09-30-11.00
2014-12-31-11.46
2015-03-31-11.00
2015-06-30-21.15
2015-09-30-5.00
2015-12-31-25.90
2016-03-31-7.29
2016-06-30-7.45
2016-09-30-12.80
2016-12-31-13.85
2017-03-31-15.53
2017-06-30-12.11
2017-09-30-10.24
2017-12-31-8.33
2018-03-31-4.47
2018-06-30-4.94
2018-09-30-3.51
2018-12-31-1.87
2019-03-31-1.67
2019-06-30-0.50
2019-09-30-0.20
2019-12-31-1.05
2020-03-31-0.70
2020-06-30-1.45
2020-09-30-2.57
2020-12-31-5.39
2021-03-31-11.05
2021-06-30-12.91
2021-09-30-12.86
2021-12-31-9.82
2022-03-31-15.39
2022-06-30-13.96
2022-09-30-12.30
2022-12-31-7.88
2023-03-31-5.19
2023-06-30-6.17
2023-09-30-4.18
2023-12-31-12.50
2024-03-31-1.31
2024-06-30-1.92
2024-09-30-2.61
2024-12-31-0.61
2025-03-31-3.19
2025-06-30-2.73
2025-09-30-3.96
2025-12-31-4.70
2026-03-31-6.25

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.